Case Report
Copyright ©The Author(s) 2019.
World J Clin Cases. Dec 26, 2019; 7(24): 4342-4348
Published online Dec 26, 2019. doi: 10.12998/wjcc.v7.i24.4342
Table 1 Clinical features of the reported series of multidrug-resistant Acinetobacter baumannii meningitis in children
Ref.Age (yr)SexAcinetobacter susceptibilityFinal regimen(s)ToxicityTreatment outcome
Kaplan et al[10]4NRMultidrug resistantCefotaxime and aminoglycoside IV, and colistin IVRNoneCure
Ng et al[11]4MaleMultidrug resistantAmikacin and colistin IV, and colistin ITChemical meningitisCure
Ozdemir et al[12]3FemaleColistinColistin and ampicillin–sulbactam IV, and colistin ITNoneCure
14FemaleColistinMeropenem and ampicillin–sulbactam IV, and rifampin PONoneCure
1MaleColistinColistin and meropenem IVNoneCure
Lee et al[13]3MaleImipenemColistin IVNoneCure
Ganjeifar et al[14]6MaleDoxycycline and rifampinColistin and rifampin IV, and colistin IVRNRCure
Jiménez-Mejías et al[15]14MaleColistinColistin IVNoneCure